Ctrl/Cmd K

Loading stock analysis…

Explore

Stocks
Screener
IPOs
News

Tools

Backtest
Portfolio
Wealth
ITR

Learn

Guides
Methodology

Company

About
Contact
Disclosures
Privacy
Terms

© 2026 Anvest. All rights reserved.

Designed & Engineered in India·harsh@anvest.in

Disclaimer: Anvest provides financial analytics, screening simulations, and planning tools for informational and educational purposes only. Anvest is not a SEBI-registered investment advisor or broker. Nothing herein constitutes investment advice or an offer to buy/sell securities. Full details on methodology and limitations are documented under Disclosures and Terms.

Stocks›Healthcare

Sanofi Consumer Healthcare India Limited

SANOFICONR · NSE · Healthcare · As of 4 Nov 2026Delayed / Sandbox EOD Data

₹3,472.60

−₹23.30 (−0.67%)(1D)

₹3,168.2052 Week Range₹5,255.00

Chart Score AI Profile Fundamentals Technicals Financials Shareholding Peers Filings

Anvest Score

78/100

Valuation

68/100

Quality

100/100

Growth

86/100

Health

99/100

Momentum

24/100

Valuation
68
Quality
100
Growth
86
Health
99
Momentum
24

Loading company profile…

Loading fundamentals…

Loading technical indicators…

Loading financial statement…

Loading shareholding…

Loading peer comparison…

Loading filings…

More Page Context

Research at a glance

Sanofi Consumer Healthcare India Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹3,472.6

Market cap

₹7,994 Cr

P/E ratio

28.6

P/B ratio

29.28

Dividend yield

Not available

ROE

Not available

RSI 14

42.73

1Y return

Not available

Sanofi Consumer Healthcare India Limited FAQs

3 topics

ExpandCollapse

Related paths

Peer links appear when comparable names are available.

Open screener Curated screens Backtest ideas

What does the Sanofi Consumer Healthcare India Limited (SANOFICONR) stock page cover?

Sanofi Consumer Healthcare India Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for SANOFICONR?

Sanofi Consumer Healthcare India Limited is currently shown with a delayed price near ₹3,472.6, P/E 28.6.

Does the SANOFICONR page provide investment advice?

No. The SANOFICONR page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring

Related insights

SANOFI

Sanofi India Limited · Healthcare

SENORES

Senores Pharmaceuticals Limited · Healthcare

SMSPHARMA

SMS Pharmaceuticals Limited · Healthcare

How to Use Anvest Intelligence Effectively: 10 Practical AI Stock Research Prompts

Master AI-assisted stock research on Indian equities. Learn how to construct grounded financial queries, audit concall guidance, verify filing citations, and avoid ungrounded AI hallucinations.

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Sanofi Consumer Healthcare India Limited operates in Drug Manufacturers - General within the Healthcare sector. The company's primary business activity is the manufacture and sale of pharmaceutical products, drugs, and pharmaceuticals, representing 100% of its turnover.

Drug Manufacturers - GeneralFounded:2023CEO/MD:Himanshu BakshiHQ:Mumbai, Maharashtra

Business profile as of 2026-08-25

Business at a Glance

The company generates revenue by developing, manufacturing, marketing, and distributing a range of consumer health products, including over-the-counter medicines, nutritional supplements, and personal care items.

What Looks Strong

QualityQuality score is supported by healthy return on equity (ROE 66.3%).
Cash FlowOperating cash flow was 2.43× total net profit in the year to 2024-12-31.

What to Watch

IPOShares trade 31.5% below its first traded close of ₹4,849.41.

Reports a single operating segment in its results filings.
These products are sold through pharmacies, retail channels, and e-commerce platforms across India.
These activities are reported on a standalone basis.

the year to 2024-12-31 (standalone): revenue ₹724 cr; net profit ₹181 cr.
the year to 2024-12-31 (standalone): operating cash flow ₹439 cr (2.4× net profit); debt/equity 0.06×.
Latest quarter to Sep 2026 (standalone): revenue ₹263 cr (up 12% year on year); net profit ₹76.6 cr.

Assurance provider details and type of assurance obtained are not applicable